Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Cell Death Differ ; 12(7): 702-12, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15818398

ABSTRACT

The aim of this study was to investigate the phenotypic plasticity of pancreatic islets of Langerhans. Quiescent adult human islets were induced to undergo a phenotypic switch to highly proliferative duct-like structures in a process characterized by a loss of expression of islet-specific hormones and transcription factors as well as a temporally related rise in the expression of markers of both duct epithelial and progenitor cells. Short-term treatment of these primitive duct-like structures with the neogenic factor islet neogenesis-associated protein (INGAP104-118) induced their reconversion back to islet-like structures in a PI3-kinase-dependent manner. These neoislets resembled freshly isolated human islets with respect to the presence and topological arrangement of the four endocrine cell types, islet gene expression and hormone production, insulin content and glucose-responsive insulin secretion. Our results suggest that adult human islets possess a remarkable degree of morphogenetic plasticity. This novel observation may have important implications for understanding pancreatic carcinogenesis and islet neogenesis.


Subject(s)
Antigens, Neoplasm/metabolism , Biomarkers, Tumor/metabolism , Islets of Langerhans/cytology , Lectins, C-Type/metabolism , Morphogenesis , Adult , Androstadienes/pharmacology , Animals , Cell Differentiation , Cell Lineage , Cell Proliferation , Cell Survival , Extracellular Signal-Regulated MAP Kinases/antagonists & inhibitors , Extracellular Signal-Regulated MAP Kinases/metabolism , Flavonoids/pharmacology , Humans , Islets of Langerhans/drug effects , Keratins/metabolism , Pancreatic Ducts/cytology , Pancreatic Ducts/drug effects , Pancreatitis-Associated Proteins , Phosphatidylinositol 3-Kinases/metabolism , Protein Kinase Inhibitors/pharmacology , Stem Cells/cytology , Wortmannin
2.
Cell Death Differ ; 10(9): 987-96, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12934073

ABSTRACT

Phenotypic change of adult pancreatic islets has been implicated in the development of certain pancreatic cancers and in islet transplant failure. The aim of this study was to characterize intracellular events that mediate changes in adult islet phenotype. Using an in vitro islet-to-duct transformation model, canine islets were induced to undergo phenotypic transformation to duct-like epithelial structures through a two-stage process. Stage one was characterized by widespread islet cell apoptosis associated with the formation of cavitary spaces within the islets. During this stage, c-Jun N-terminal regulated kinase (JNK) and caspase-3 activities were elevated, while extracellular signal-regulated kinase (ERK) and Akt activities were decreased. The second stage of the process was characterized by an inversion in the balance in activity between these signal transduction pathways and by a concomitant decrease in apoptosis. The transformed islets were no longer immunoreactive for islet cell hormones, but expressed the duct epithelial cell marker CK-AE1/AE3. In contrast to islet cells, these duct epithelial cells were highly proliferative. To clarify the role of the identified changes in signal transduction events, we performed additional studies using pharmacological inhibitors of enzyme activity and demonstrated that inhibition of JNK and caspase-3 activity prevented cystic transformation. Our results indicate that the balance in signaling activity between ERK/Akt and JNK/caspase-3 appears to be an important regulator of islet cell death and differentiation.


Subject(s)
Apoptosis , Islets of Langerhans/cytology , Pancreatic Ducts/cytology , Protein Serine-Threonine Kinases , Signal Transduction , Animals , Caspase 3 , Caspases/metabolism , Cell Differentiation , Cell Division , Cells, Cultured , Dogs , Epithelial Cells/cytology , Epithelial Cells/enzymology , Female , Islets of Langerhans/enzymology , Kinetics , Male , Mitogen-Activated Protein Kinases/metabolism , Pancreatic Ducts/enzymology , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins c-akt
3.
Ann Thorac Surg ; 72(5): 1465-71; discussion 1471-2, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11722027

ABSTRACT

BACKGROUND: This study evaluates whether systemic steroid pretreatment enhances neuroprotection during deep hypothermic circulatory arrest (DHCA) compared with steroid in cardiopulmonary bypass (CPB) prime. METHODS: Four-week-old piglets randomly placed into two groups (n = 5 per group) were given methylprednisolone (30 mg/kg) into the pump prime (group PP), or pretreated intravenously 4 hours before CPB (group PT). All animals underwent 100 minutes of DHCA (15 degrees C), were weaned off CPB, and were sacrificed 6 hours later. Postoperative changes in body weight, bioimpedance, and colloid oncotic pressure (COP) were measured. Cerebral trypan blue content, immunohistochemical evaluation of transforming growth factor-beta1 (TGF-beta1) expression, and caspase-3 activity were performed. RESULTS: Percentage weight gain (group PP 25.0% +/- 10.4% versus group PT 12.5% +/- 4.0%; p = 0.036), and percentage decrease in bioimpedance (PP 37.2% +/- 14.5% versus PT 15.6% +/- 7.9%; p = 0.019) were significantly lower, whereas postoperative COP was significantly higher in group PT versus group PP (PT 15.3 +/- 1.8 mm Hg versus PP 11.6 +/- 0.8 mm Hg; p = 0.003). Cerebral trypan blue (ng/g dry tissue) was significantly lower in group PT (PT 5.6 x 10(-3) +/- 1.1 x 10(-3) versus PP 9.1 x 10(-3) +/- 5.7 x 10(-4); p = 0.001). Increased TGF-beta1 expression and decreased caspase-3 activity were shown in group PT. CONCLUSIONS: Systemic steroid pretreatment significantly reduced total body edema and cerebral vascular leak and was associated with better immunohistochemical indices of neuroprotection after DHCA.


Subject(s)
Brain Injuries/prevention & control , Cardiopulmonary Bypass/adverse effects , Glucocorticoids/therapeutic use , Heart Arrest, Induced/adverse effects , Methylprednisolone Hemisuccinate/therapeutic use , Neuroprotective Agents/therapeutic use , Animals , Brain Injuries/etiology , Brain Injuries/metabolism , Brain Injuries/pathology , Electric Impedance , Preoperative Care , Swine
SELECTION OF CITATIONS
SEARCH DETAIL
...